Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
Therapeutic Effects of Various Initial Combination Chemotherapy Including Clarithromycin Against Mycobacterium avium Complex Pulmonary Disease
Chest, 06/26/09
Hasegawa N et al. - The higher dose of CAM allowed better culture conversion. Daily combination chemotherapy including CAM 800mg seems appropriate as initial treatment against treatment-naive nodular and bronchiectatic MAC pulmonary disease.
Related Articles
Clarithromycin Resistance and Efficacy of Clarithromycin-Containing Triple Eradication Therapy for Helicobacter pylori Infection in Type 2 Diabetes Mellitus Patients
Southern Medical Journal, 11/09/09
Relevance Score: 87%
Clarithromycin–Amoxycillin-Containing Triple Therapy: A Valid Empirical First-Line Treatment for Helicobacter pylori Eradication in Hong Kong
Helicobacter, 11/09/09
Relevance Score: 87%
Physiologically-Based Pharmacokinetic Model of Mechanism-Based Inhibition of CYP3A by Clarithromycin
Drug Metabolism and Disposition, 11/06/09
Relevance Score: 87%
Analysis of Clarithromycin Resistance and CagA Status in Helicobacter pylori Using Feces from Children in Thailand
Journal of Clinical Microbiology, 10/08/09
Relevance Score: 87%
Clarithromycin, a potent inhibitor of CYP3A, greatly increases exposure to oral S-ketamine
European Journal of Pain, 11/10/09
Relevance Score: 85%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Sedation during Flexible Bronchoscopy in Patients with Pre-Existing Respiratory Failure: Midazolam versus Midazolam plus Alfentanil
Respiration, 12/18/09
Taurolidine in the prevention and therapy of lung metastases
European Journal of Cardio-Thoracic Surgery, 12/18/09
Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil
Rheumatology, 12/18/09
Today in Pulm/Thoracic Infections...keeping you current
Receive free subspecialty "5-minute updates" via email
Poor Late Survival After Surgical Treatment of Pleural Empyema
World Journal of Surgery, 12/18/09
PCR in blood for diagnosis of invasive pneumococcal disease: systematic review and meta-analysis
Journal of Clinical Microbiology, 12/18/09
Serologically verified human bocavirus pneumonia in children
Pediatric Pulmonology, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


